Near-Infrared MAO A Inhibitor (NMI) Outperformed FDA-Approved Chemotherapeutic Agents in Brain and Other Cancers: A Bioinformatic Analysis of NCI60 Screening Data

Our previous work has shown that monoamine oxidase A (MAO A) is overexpressed in glioma and prostate cancer. Near-infrared dye conjugate MAO A Inhibitor (NMI) inhibited the growth of these cancers. This study investigated the effects of NMI on other cancers by NCI60 screening. Our results showed tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qianhua, Lian, Yuxuan, Qian, Yihan, Shih, Jean C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534240/
https://www.ncbi.nlm.nih.gov/pubmed/34679383
http://dx.doi.org/10.3390/brainsci11101318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534240/
https://www.ncbi.nlm.nih.gov/pubmed/34679383
http://dx.doi.org/10.3390/brainsci11101318

Ejemplares similares